Table 4.

Comparative Course Characteristics of Patients with Schizophrenia in Current Study (Butajira) and That of DOSMD

Course Characteristics (Categories)	% Patients in Course Categories
	Butajira	DOSMD—Developing Countries	DOSMD—Developed Countries
Continuous illness with psychotic episodes or residual symptoms	30.8	35.7	60.9
Psychotic (≤5% of follow-up)	36.8	18.4	18.7
Psychotic (>75% of follow-up)	1.3	15.9	20.2
Complete remission (>75% of follow-up)	5.7	38.3	22.3
On antipsychotic (>75% of follow-up)	12.9	15.9	60.8
Never on antipsychotics	9.1	5.9	2.5

DOSMD, Determinants of Outcome in Severe Mental Disorders.